Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

BGI to Open Sequencing Facility in Singapore

publication date: Sep 25, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BGI, the genomics powerhouse headquartered in Shenzhen, will build a next generation sequencing facility in Singapore as part of a partnership with INEX Innovations Exchange, a Singapore-based women’s health diagnostics company. BGI has developed a non-invasive test that uses a blood sample from a pregnant mother to screen for three chromosomal abnormalities in the fetus. One of the abnormalities results in Down Syndrome. The test replaces an amniocentesis procedure, which has a 1% chance of causing a miscarriage. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...